NASDAQ:XLRN

Acceleron Pharma SEC Filings & 10K Form

$120.19
-2.62 (-2.13 %)
(As of 07/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$119.85
$123.74
50-Day Range
$115.25
$133.44
52-Week Range
$85.58
$146.15
Volume294,977 shs
Average Volume341,824 shs
Market Capitalization$7.30 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.36

Acceleron Pharma (NASDAQ:XLRN) SEC Filings

DateFilerForm TypeView
07/02/2021
8:15 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
6:49 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2021
4:14 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2021
5:53 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
5:48 PM
Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
7:12 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2021
6:24 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2021
3:10 PM
Acceleron Pharma (Filer)
Form DEFA14A
04/05/2021
7:27 PM
Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
7:17 PM
Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
6:22 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2021
5:08 PM
Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
5:00 PM
Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:17 PM
Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:17 PM
Acceleron Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2021
3:11 PM
Acceleron Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/08/2021
9:15 AM
Acceleron Pharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/04/2021
6:21 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2021
6:50 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
6:46 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
6:42 PM
Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
6:35 PM
Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
Form 4/A
02/02/2021
6:15 PM
Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
6:10 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
6:00 PM
Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
5:52 PM
Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
5:49 PM
Acceleron Pharma (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
5:46 PM
Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
5:41 PM
Acceleron Pharma (Issuer)
Kearney Terrence C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
5:38 PM
Acceleron Pharma (Issuer)
Hite Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
5:31 PM
Acceleron Pharma (Issuer)
Hamill Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
5:26 PM
Acceleron Pharma (Issuer)
Nader Francois (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
6:11 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2021
6:12 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
6:09 PM
Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
6:05 PM
Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
6:03 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
5:58 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2020
5:24 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2020
5:24 PM
Acceleron Pharma (Issuer)
Acceleron Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
5:08 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
9:05 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
3:14 PM
Acceleron Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
3:08 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
6:27 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
6:14 PM
Acceleron Pharma (Issuer)
Kearney Terrence C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2020
10:07 AM
Acceleron Pharma (Filer)
Form CT ORDER
10/02/2020
6:56 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2020
8:23 AM
Acceleron Pharma (Issuer)
Hamill Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2020
8:13 AM
Acceleron Pharma (Issuer)
Hamill Laura (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2020
4:27 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2020
3:51 PM
Acceleron Pharma (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
9:03 AM
Acceleron Pharma (Subject)
FMR LLC (Filed by)
Form SC 13G/A
09/09/2020
4:49 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
3:07 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
6:30 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2020
5:27 PM
Acceleron Pharma (Issuer)
BRISTOL MYERS SQUIBB CO (Reporting)
CELGENE CORP /DE/ (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
5:57 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
4:24 PM
Acceleron Pharma (Issuer)
BRISTOL MYERS SQUIBB CO (Reporting)
CELGENE CORP /DE/ (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
4:22 PM
Acceleron Pharma (Issuer)
BRISTOL MYERS SQUIBB CO (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/26/2020
4:22 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2020
2:17 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2020
7:32 PM
Acceleron Pharma (Issuer)
Hite Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
7:23 PM
Acceleron Pharma (Issuer)
Hite Christopher (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/04/2020
4:17 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2020
3:14 PM
Acceleron Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
3:10 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2020
4:06 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2020
4:30 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2020
4:29 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2020
4:26 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2020
3:39 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
7:41 AM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2020
3:13 PM
Acceleron Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2020
3:10 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
8:26 AM
Acceleron Pharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/10/2020
5:01 PM
Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
Form 4/A
02/10/2020
4:50 PM
Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
Form 4/A
01/27/2020
3:14 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2020
6:32 PM
Acceleron Pharma (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:59 PM
Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:48 PM
Acceleron Pharma (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:45 PM
Acceleron Pharma (Issuer)
Kearney Terrence C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:41 PM
Acceleron Pharma (Issuer)
George Jean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:37 PM
Acceleron Pharma (Issuer)
Nader Francois (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:33 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:27 PM
Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:21 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
4:18 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
3:20 PM
Acceleron Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
3:36 PM
Acceleron Pharma (Issuer)
Zakrzewski Joseph S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:51 PM
Acceleron Pharma (Issuer)
Veness Adam M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:48 PM
Acceleron Pharma (Issuer)
KANGO SUJAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:45 PM
Acceleron Pharma (Issuer)
Quisel John D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:41 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:37 PM
Acceleron Pharma (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:32 PM
Acceleron Pharma (Issuer)
Backstrom Jay T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:24 PM
Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2020
8:20 PM
Acceleron Pharma (Issuer)
Malik Kemal (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/17/2019
5:39 PM
Acceleron Pharma (Issuer)
MCLAUGHLIN KEVIN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.